Brief: Kiora Pharmaceuticals Says Certificate Of Amendment Effects A 1-For-9 Reverse Stock Split Of Company's Common Stock
07/06/2024 12:37
June 7 (Reuters) - Kiora Pharmaceuticals Inc KPRX.O :
* KIORA PHARMACEUTICALS: ON JUNE 6, FILED WITH SECRETARY OF
STATE
OF DELAWARE CERTIFICATE OF AMENDMENT TO CO'S RESTATED
CERTIFICATE OF INCORPORATION
* KIORA PHARMACEUTICALS INC: CERTIFICATE OF AMENDMENT
EFFECTS A
1-FOR-9 REVERSE STOCK SPLIT OF COMPANY'S COMMON STOCK
Source text for Eikon: ID:n0001372514-24-000057
Further company coverage: KPRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kiora Pharmaceuticals
See all newsKiora Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Kiora Pharmaceuticals, Inc. expected to post a loss of 62 cents a share - Earnings Preview
Brief: Kiora Pharmaceuticals Inc - Enters Securities Purchase Agreement On April 3, 2026 - SEC Filing
Kiora Pharmaceuticals posts 2025 net loss as expenses rise
Brief: Kiora Pharmaceuticals Files For Mixed Shelf Offering Of Up To $100 Million- SEC Filing